| Primary |
| Diabetes Mellitus |
63.5% |
| Type 2 Diabetes Mellitus |
9.6% |
| Device Therapy |
5.8% |
| Hypertension |
5.8% |
| Spinal Compression Fracture |
3.8% |
| Ankle Swelling |
1.9% |
| Diabetes Mellitus Non-insulin-dependent |
1.9% |
| Diabetic Relative |
1.9% |
| Drug Poisoning |
1.9% |
| Prophylaxis |
1.9% |
| Tendonitis |
1.9% |
|
| Ketosis |
15.6% |
| Acetonaemia |
9.4% |
| Syncope |
9.4% |
| Ketoacidosis |
6.3% |
| No Adverse Event |
6.3% |
| Renal Disorder |
6.3% |
| Renal Failure Chronic |
6.3% |
| Anaemia |
3.1% |
| Atrial Fibrillation |
3.1% |
| Blood Urea Increased |
3.1% |
| Death |
3.1% |
| Decreased Activity |
3.1% |
| Decreased Appetite |
3.1% |
| Device Malfunction |
3.1% |
| Dizziness |
3.1% |
| Fracture |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Haemorrhage |
3.1% |
| Hospitalisation |
3.1% |
| Hypoglycaemia |
3.1% |
|
| Secondary |
| Diabetes Mellitus |
49.8% |
| Type 2 Diabetes Mellitus |
10.8% |
| Hypertension |
10.0% |
| Device Therapy |
7.9% |
| Coronary Artery Disease |
2.5% |
| Diabetic Relative |
2.5% |
| Prophylaxis |
2.5% |
| Thrombosis Prophylaxis |
2.5% |
| Glaucoma |
1.2% |
| Hyperuricaemia |
1.2% |
| Hypothyroidism |
1.2% |
| Oedema |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
| Renal Failure |
1.2% |
| Cardiac Disorder |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Spinal Compression Fracture |
0.8% |
| Type 1 Diabetes Mellitus |
0.8% |
| Dyslipidaemia |
0.4% |
| Gastritis |
0.4% |
|
| Renal Failure Chronic |
22.2% |
| Decreased Appetite |
7.9% |
| Gastrointestinal Haemorrhage |
7.9% |
| Renal Failure |
7.9% |
| Acute Myocardial Infarction |
6.3% |
| Iron Deficiency Anaemia |
6.3% |
| Stevens-johnson Syndrome |
4.8% |
| Dizziness |
3.2% |
| Jaundice Neonatal |
3.2% |
| Pancreatitis |
3.2% |
| Pneumonia |
3.2% |
| Premature Baby |
3.2% |
| Progesterone Decreased |
3.2% |
| Sepsis |
3.2% |
| Tachycardia |
3.2% |
| Truncus Arteriosus Persistent |
3.2% |
| Wrong Drug Administered |
3.2% |
| Ageusia |
1.6% |
| Anaemia |
1.6% |
| Cardiac Arrest |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.9% |
| Drug Use For Unknown Indication |
21.0% |
| Diabetes Mellitus |
12.6% |
| Type 2 Diabetes Mellitus |
9.5% |
| Hypertension |
6.9% |
| Blood Cholesterol Increased |
2.5% |
| Prophylaxis |
2.3% |
| Pain |
2.1% |
| Type 1 Diabetes Mellitus |
1.9% |
| Depression |
1.7% |
| Osteoporosis |
1.7% |
| Peritoneal Dialysis |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Hepatitis C |
1.3% |
| Multiple Myeloma |
1.3% |
| Nausea |
1.3% |
| Blood Pressure |
1.0% |
| End Stage Renal Disease (Esrd) |
1.0% |
| Blood Pressure Systolic Increased |
0.8% |
| Diabetic Neuropathy |
0.8% |
|
| Drug Exposure During Pregnancy |
7.6% |
| Drug Ineffective |
7.6% |
| Respiratory Failure |
7.6% |
| Weight Increased |
7.6% |
| Hypotension |
6.1% |
| Metabolic Acidosis |
6.1% |
| Premature Baby |
6.1% |
| Vomiting |
6.1% |
| Hypoglycaemia |
4.5% |
| Induration |
4.5% |
| Polyhydramnios |
4.5% |
| Respiratory Tract Inflammation |
4.5% |
| Sleep Attacks |
4.5% |
| Sleep Disorder |
4.5% |
| Anaemia |
3.0% |
| Asthenia |
3.0% |
| Blood Glucose Increased |
3.0% |
| Coronary Artery Occlusion |
3.0% |
| Delusion |
3.0% |
| Drug Hypersensitivity |
3.0% |
|
